The costs of managing patients with malignant glioma at a neuro-oncology clinic

British Journal of Neurosurgery

Volumn 12, Issue 2, 1998, Pages 118-122

  Latif, A Z ^a   Signorini, D ^a   Gregor, A ^a   Whittle, I R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Glioma; Health economics

Indexed keywords

CARBOPLATIN; LOMUSTINE; PROCARBAZINE; TAUROMUSTINE; VINCRISTINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; FEMALE; FOLLOW UP; GLIOBLASTOMA; HOSPITAL COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

BRAIN NEOPLASMS; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; GLIOMA; HOSPITAL COSTS; HUMANS; MALE; ONCOLOGY SERVICE, HOSPITAL; PROGNOSIS; QUALITY-ADJUSTED LIFE YEARS; SCOTLAND; STATE MEDICINE; SURVIVAL RATE;

EID: 0031899718     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688699845230     Document Type: Article

References (24)

1. Whittle IR. Management of primary malignant brain tumours. J Neurol Neurosurg Psychiatry 1996;60:2-5.
2. Fine HA. The basis for current treatment recommendations for malignant gliomas. J Neurooncol 1994;20:11-20.
3. Cohadon F. Indications for surgery in the management of gliomas. Adv Tech Stand Neurosurgery 1990;17:189-234.
4. Grant R, Whittle IR, Collie DA, Gregor A, Ironside J. Referral patterns and management of patients with malignant brain tumours in south east Scotland. Hlth Bull 1996;54:212-22.
5. Whittle IR, Denholm SW, Gregor A. Management of patients aged over 60 years with supratentorial gliomas: lessons from an audit. Surg Neurol 1991;36:106-11.
6. Walker MD et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trials. J Neurosurg 1978;49:333-43.
7. Pickard JD et al. Steps towards cost-benefit analysis of a regional neurosurgical care. BMJ 1990;301:629-35.
8. Jennett B, Pickard J. Economic aspect of neurosurgery. Adv Tech Stand Neurosurg 1992;19:123-43
9. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma; pathologic criteria and prognostic implications. Cancer 1985;56:1106-11.
10. MRC Brain Tumour Working Party. Prognostic factors for high grade gliomas: development of a prognostic index. J Neurooncol 1990;9:47-55.
11. Latif AZB, Signorini D, Grant R, Gregor A, Ironside, Whittle IR. Application of the MRC Brain tumour prognostic index to patients managed in Edinburgh. J Neurol Neurosurg Psychiat, in press.
12. Robinson R. Economic evaluation and health care: what does it mean? BMJ, 1993;307:670-73.
13. Burner ST, Waldo DR, McKusick DR. National Health expenditures projections through 2030. Hlth Care Financing Rev 1992;14:1-29.
14. Black PM. Allocation of medical resources: problems faced by the practicing neuro surgeons. Neurosurgery 1990;27(1):156-8.
15. Mason J, Drummond M, Torrance G. Some guidelines on the use of cost effectiveness league tables. BMJ 1993;306:570-2.
16. Smith A. Qualms about Qaly. Lancet, 1987;1134-6.
17. Puma JL, Edward FL. Quality adjusted life years. Ethical implications for physicians and policymakers. JAMA 1990;263:2917-21.
18. Carr-Hill RA, Morris J. Current practice in obtaining the 'Q' in QALYs - a cautionary note. BMJ 1991;303:699-701.
19. Little JM. A method of calculating the value of palliative care of cancer patients. Aust N Z J Surg 1987;57:393-7.
20. Thomas R, James N, Guerrero D. Hypofractionated radiotherapy as a palliative treatment in poor prognosis patient with high grade glioma. Radiother Oncol 1994;33:113-18.
21. Stenning SP, Freedman LS, Bleehan NM. An overview of published reults from randomized studies of nitrossureas in primary high grade malignant glioma. B J Cancer 1987;56:89-90.
22. Penar PL, Wilson JT. Cost and survival analysis of metastatic cerebral tumours treated by resection and radiation. Neurosurgery 1994;34:888-94.
23. Rutigliano MJ et al. Cost effectiveness analysis of surgery and stereotactic radiosurgery in cerebral metastasis. Neurosurgery 1995;37:444-58.
24. Selby PJ et al. The development of a method for assessing the quality of life of cancer patients. J Cancer 1984;15:13-22.